Dr Emily Ann Ptasnik, DO | |
18101 Oakwood Blvd, Dearborn, MI 48124-4089 | |
(313) 593-7000 | |
Not Available |
Full Name | Dr Emily Ann Ptasnik |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 18101 Oakwood Blvd, Dearborn, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801470059 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 5151014993 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Emily Ann Ptasnik, DO 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (313) 593-7000 | Dr Emily Ann Ptasnik, DO 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (313) 593-7000 |
News Archive
Pancreatic cancer carries a very bleak prognosis for patients. However, a recent breakthrough by two research teams, including one at the Hôpital Maisonneuve-Rosemont (CIUSSS-EST, Montreal) and University of Montreal, has opened the door to a better understanding of the molecular mechanisms that cause this cancer to develop.
A personal, handheld device emitting high-intensity ultraviolet light to disinfect areas by killing the novel coronavirus is now feasible, according to researchers at Penn State, the University of Minnesota and two Japanese universities.
In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.
Knowing the environmental and human-related variables that characterize the favorable areas for the incidence of the West Nile virus, a flavivirus that is transmitted from birds to humans by mosquitoes, is essential to identify those places in Europe at high risk of experiencing outbreaks, even before these are registered, thus enabling preventive measures to be taken.
The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.
› Verified 1 days ago
Taylor Adlam, MD Dermatology Medicare: Medicare Enrolled Practice Location: 18100 Oakwood Blvd Ste 300, Dearborn, MI 48124 Phone: 313-240-4900 | |
Daniel J Myers, Dermatology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 800-356-7836 | |
Jennifer Heyl, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: Oakwood Hospital & Medical Center, 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Hany Deirawan, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 18100 Oakwood Blvd Ste 300, Dearborn, MI 48124 Phone: 313-240-4900 | |
Chiara Jordan Rosenbaum, DO Dermatology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2581 Fax: 313-436-2071 | |
Johanna Chapel, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2814 Monroe St, Dearborn, MI 48124 Phone: 313-561-5311 Fax: 313-561-2504 | |
Arathi Rajendran Goldsmith, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 835 Mason St Ste C200, Dearborn, MI 48124 Phone: 313-274-5810 Fax: 313-274-1499 |